{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T00:06:04Z","timestamp":1794701164263,"version":"4.9.1"},"reference-count":78,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1097\/icu.0000000000000596","type":"journal-article","created":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T00:23:43Z","timestamp":1563323023000},"page":"401-406","source":"Crossref","is-referenced-by-count":25,"title":["Update on the clinical assessment and management of thyroid eye disease"],"prefix":"10.1097","volume":"30","author":[{"given":"Jonathan C.P.","family":"Roos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachna","family":"Murthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-18-20200527","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1002\/lary.27447","article-title":"Objectively measuring observer attention in severe thyroid-associated orbitopathy: a 3D study","volume":"129","author":"Liao","year":"2019","journal-title":"Laryngoscope"},{"key":"R2-18-20200527","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1089\/thy.2017.0365","article-title":"Death by suicide in Graves\u2019 disease and Graves\u2019 orbitopathy: a nationwide Danish Register Study","volume":"27","author":"Ferl\u00f8v-Schwensen","year":"2017","journal-title":"Thyroid"},{"key":"R3-18-20200527","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1097\/IOP.0000000000001150","article-title":"Grading severity and activity in thyroid eye disease","volume":"34","author":"Dolman","year":"2018","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"R4-18-20200527","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/IOP.0000000000001080","article-title":"Soft tissue metrics in thyroid eye disease: an international thyroid eye disease society reliability study","volume":"34","author":"Mawn","year":"2018","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"R5-18-20200527","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1167\/tvst.7.5.14","article-title":"Development and validation of the Singapore Thyroid Eye Disease Quality of Life Questionnaire","volume":"7","author":"Wong","year":"2018","journal-title":"Transl Vis Sci Technol"},{"key":"R6-18-20200527","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3389\/fendo.2019.00192","article-title":"Evaluation of quality of life in the Brazilian Graves\u2019 disease population: focus on mild and moderate Graves\u2019 orbitopathy patients","volume":"10","author":"Villagelin","year":"2019","journal-title":"Front Endocrinol (Lausanne"},{"key":"R7-18-20200527","doi-asserted-by":"crossref","first-page":"7602419","DOI":"10.1155\/2019\/7602419","article-title":"Evaluation of the Graves\u2019 Orbitopathy-Specific Quality of Life Questionnaire in the Mainland Chinese Population","volume":"2019","author":"Zeng","year":"2019","journal-title":"J Ophthalmol"},{"key":"R8-18-20200527","first-page":"1341","article-title":"Establishing the usefulness of the GO-QOL in a UK hospital-treated population with thyroid eye disease in the CIRTED trial","volume":"23","author":"Dietrich","year":"2018","journal-title":"Psychol Health Med"},{"key":"R9-18-20200527","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000477803","article-title":"Does Graves\u2019 orbitopathy ever disappear? Answers to an old question","volume":"6","author":"Sabini","year":"2017","journal-title":"Eur Thyroid J"},{"key":"R10-18-20200527","first-page":"272","article-title":"Quality of life in patients with orbitopathy - single center experience","volume":"44","author":"Char\u0105\u017cka","year":"2018","journal-title":"Pol Merkur Lekarski"},{"key":"R11-18-20200527","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/01676830.2017.1314510","article-title":"Patterns of visual field changes in thyroid eye disease","volume":"36","author":"Choi","year":"2017","journal-title":"Orbit"},{"key":"R14-18-20200527","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1210\/jc.2005-2813","article-title":"Thyrotropin receptor autoantibodies are independent risk factors for Graves\u2019 ophthalmopathy and help to predict severity and outcome of the disease","volume":"91","author":"Eckstein","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R15-18-20200527","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41433-018-0242-9","article-title":"Serial TSH-receptor antibody levels to guide the management of thyroid eye disease: the impact of smoking, immunosuppression, radio-iodine, and thyroidectomy","volume":"33","author":"Roos","year":"2019","journal-title":"Eye (Lond"},{"key":"R16-18-20200527","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41433-018-0303-0","article-title":"Comment on: A British Ophthalmic Surveillance Unit (BOSU) study into dysthyroid optic neuropathy in the United Kingdom","volume":"33","author":"Roos","year":"2019","journal-title":"Eye (Lond"},{"key":"R17-18-20200527","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s40618-018-0943-8","article-title":"Serum antibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves\u2019 disease and Graves\u2019 orbitopathy","volume":"42","author":"Marin\u00f2","year":"2019","journal-title":"J Endocrinol Invest"},{"key":"R18-18-20200527","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s12020-017-1467-2","article-title":"The tear cytokine profile in patients with active Graves\u2019 orbitopathy","volume":"59","author":"Yang","year":"2018","journal-title":"Endocrine"},{"key":"R19-18-20200527","doi-asserted-by":"crossref","first-page":"10792","DOI":"10.1038\/s41598-018-29113-2","article-title":"Differential profiling of lacrimal cytokines in patients suffering from thyroid-associated orbitopathy","volume":"8","author":"Kishazi","year":"2018","journal-title":"Sci Rep"},{"key":"R20-18-20200527","doi-asserted-by":"crossref","first-page":"16936","DOI":"10.1038\/s41598-018-35096-x","article-title":"Tear proteins calcium binding protein A4 (S100A4) and prolactin induced protein (PIP) are potential biomarkers for thyroid eye disease","volume":"8","author":"Chng","year":"2018","journal-title":"Sci Rep"},{"key":"R21-18-20200527","doi-asserted-by":"crossref","first-page":"7121","DOI":"10.1007\/s00216-018-1313-2","article-title":"Lipidomic differentiation of Graves\u2019 ophthalmopathy in plasma and urine from Graves\u2019 diseasepatients","volume":"410","author":"Byeon","year":"2018","journal-title":"Anal Bioanal Chem"},{"key":"R22-18-20200527","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s12886-018-0969-x","article-title":"Oxidative stress markers in tears of patients with Graves\u2019 orbitopathy and their correlation with clinical activity score","volume":"18","author":"Choi","year":"2018","journal-title":"BMC Ophthalmol"},{"key":"R23-18-20200527","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.12659\/MSM.912310","article-title":"Altered corneal nerves in Chinese thyroid-associated ophthalmopathy patients observed by in vivo confocal microscopy","volume":"25","author":"Wu","year":"2019","journal-title":"Med Sci Monit"},{"key":"R24-18-20200527","doi-asserted-by":"crossref","first-page":"7065713","DOI":"10.1155\/2019\/7065713","article-title":"Value of infrared thermography camera attached to a smartphone for evaluation and follow-up of patients with Graves\u2019 ophthalmopathy","volume":"2019","author":"Minatel Riguetto","year":"2019","journal-title":"Int J Endocrinol"},{"key":"R25-18-20200527","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12886-019-1064-7","article-title":"A novel method for quantifying the biomechanical parameters of orbital soft tissue using a corneal dynamic scheimpflug analyser: a retrospective study","volume":"19","author":"Hwang","year":"2019","journal-title":"BMC Ophthalmol"},{"key":"R26-18-20200527","first-page":"688","article-title":"A study on observing the central macular choroidal thickness of thyroid-associated ophthalmopathy patients with spectral-domain optical coherence tomography","volume":"54","author":"Zhu","year":"2018","journal-title":"Zhonghua Yan Ke Za Zhi"},{"key":"R27-18-20200527","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/01676830.2018.1446539","article-title":"Changes in peripapillary blood vessel density in Graves\u2019 orbitopathy after orbital decompression surgery as measured by optical coherence tomography angiography","volume":"38","author":"Lewis","year":"2019","journal-title":"Orbit"},{"key":"R28-18-20200527","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3928\/01913913-20180802-01","article-title":"Optical coherence tomography thickness measurements of the extraocular rectus muscle tendons in Graves\u2019 ophthalmopathy","volume":"55","author":"De-Pablo-G\u00f3mez-de-Lia\u00f1o","year":"2018","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"R29-18-20200527","doi-asserted-by":"crossref","first-page":"3529395","DOI":"10.1155\/2018\/3529395","article-title":"Analysis in choroidal thickness in patients with Graves\u2019 ophthalmopathy using spectral-domain optical coherence tomography","volume":"2018","author":"Yu","year":"2018","journal-title":"J Ophthalmol"},{"key":"R31-18-20200527","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.joco.2018.11.003","article-title":"Correlation of peripapillary nerve fiber layer thickness with visual outcomes after decompression surgery in subclinical and clinical thyroid-related compressive optic neuropathy","volume":"31","author":"Rajabi","year":"2018","journal-title":"J Curr Ophthalmol"},{"key":"R32-18-20200527","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.ophtha.2018.07.001","article-title":"Central retinal vein occlusion with chorioretinal folds secondary to active thyroid eye disease","volume":"125","author":"Roelofs","year":"2018","journal-title":"Ophthalmology"},{"key":"R33-18-20200527","first-page":"301","article-title":"Flow changes in orbital vessels detected with color Doppler ultrasound in patients with early dysthyroid optic neuropathy","volume":"57","author":"Le\u0161in","year":"2018","journal-title":"Acta Clin Croat"},{"key":"R34-18-20200527","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/01676830.2018.1513537","article-title":"Color Doppler imaging of orbital vasculature before and after orbital decompression in thyroid eye disease","volume":"38","author":"Jamshidian-Tehrani","year":"2019","journal-title":"Orbit"},{"key":"R35-18-20200527","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41433-018-0304-z","article-title":"T2-relaxation mapping and fat fraction assessment to objectively quantify clinical activity in thyroid eye disease: an initial feasibility study","volume":"33","author":"Das","year":"2019","journal-title":"Eye (Lond"},{"key":"R36-18-20200527","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/01676830.2017.1423343","article-title":"Novel use of nonecho-planar diffusion weighted MRI in monitoring disease activity and treatment response in active Grave's orbitopathy: an initial observational cohort study","volume":"37","author":"Lingam","year":"2018","journal-title":"Orbit"},{"key":"R37-18-20200527","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.diii.2018.02.007","article-title":"Diffusion-weighted magnetic resonance imaging of extraocular muscles in patients with Grave's ophthalmopathy using turbo field echo with diffusion-sensitized driven-equilibrium preparation","volume":"99","author":"Hiwatashi","year":"2018","journal-title":"Diagn Interv Imaging"},{"key":"R38-18-20200527","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12902-019-0340-0","article-title":"Efficacy of 99mTc-DTPA SPECT\/CT in diagnosing orbitopathy in Graves\u2019 disease","volume":"19","author":"Szumowski","year":"2019","journal-title":"BMC Endocr Disord"},{"key":"R39-18-20200527","first-page":"457","article-title":"Evaluation of inflammatory activity in thyroid associated ophthalmopathy by SPECT\/CT with 99mTc-DTPA","volume":"43","author":"Liu","year":"2018","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"R40-18-20200527","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/cpf.12548","article-title":"Technetium-99m-antitumour necrosis factor alpha scintigraphy as promising predictor of response to corticotherapy in chronic active Graves\u2019 ophthalmopathy","volume":"39","author":"de Lacerda","year":"2019","journal-title":"Clin Physiol Funct Imaging"},{"key":"R41-18-20200527","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1038\/s41433-018-0144-x","article-title":"A British Ophthalmological Surveillance Unit (BOSU) study into dysthyroid optic neuropathy in the United Kingdom","volume":"32","author":"Wong","year":"2018","journal-title":"Eye (Lond"},{"key":"R42-18-20200527","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/IOP.0000000000001003","article-title":"Orbital radiotherapy combined with corticosteroid treatment for thyroid eye disease-compressive optic neuropathy","volume":"34","author":"Gold","year":"2018","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"R43-18-20200527","doi-asserted-by":"crossref","first-page":"652","DOI":"10.4158\/EP-2018-0047","article-title":"Retrospective analysis of patients with graves orbitopathy treated by pulses of methylprednisolone, with a focus on adverse events","volume":"24","author":"Schovanek","year":"2018","journal-title":"Endocr Pract"},{"key":"R45-18-20200527","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s12020-018-1823-x","article-title":"Therapy of moderate-to-severe Graves\u2019 orbitopathy with intravenous methylprednisolone pulses is not associated with loss of bone mineral density","volume":"64","author":"Rymuza","year":"2019","journal-title":"Endocrine"},{"key":"R46-18-20200527","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41433-018-0303-0","article-title":"Comment on: a British Ophthalmic Surveillance Unit (BOSU) study into dysthyroid optic neuropathy in the United Kingdom","volume":"33","author":"Roos","year":"2019","journal-title":"Eye (Lond"},{"key":"R47-18-20200527","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/cen.13834","article-title":"Early use of steroid-sparing agents in the inactivation of moderate-to-severe active thyroid eye disease: a step-down approach","volume":"89","author":"Sipkova","year":"2018","journal-title":"Clin Endocrinol (Oxf"},{"key":"R49-18-20200527","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S2213-8587(18)30021-4","article-title":"Combined immunosuppression and radiotherapy in thyroid eye disease (CIRTED): a multicentre, 2 \u00d7 2 factorial, double-blind, randomised controlled trial","volume":"6","author":"Rajendram","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R50-18-20200527","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S2213-8587(18)30020-2","article-title":"Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves\u2019 orbitopathy (MINGO): a randomised, observer-masked, multicentre trial","volume":"6","author":"Kahaly","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R51-18-20200527","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1089\/thy.2018.0506","article-title":"Prostaglandin F2-Alpha Eye Drops (Bimatoprost) in Graves\u2019 orbitopathy: a randomized controlled double-masked crossover trial (BIMA Trial)","volume":"29","author":"Draman","year":"2019","journal-title":"Thyroid"},{"key":"R53-18-20200527","doi-asserted-by":"crossref","first-page":"5912","DOI":"10.1167\/iovs.18-25134","article-title":"The effect of prostaglandin analogue bimatoprost on thyroid-associated orbitopathy","volume":"59","author":"Choi","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R54-18-20200527","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41433-018-0265-2","article-title":"The insulin-like growth factor-I receptor and its role in thyroid-associated ophthalmopathy","volume":"33","author":"Smith","year":"2019","journal-title":"Eye (Lond"},{"key":"R55-18-20200527","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1056\/NEJMoa1614949","article-title":"Teprotumumab for thyroid-associated ophthalmopathy","volume":"376","author":"Smith","year":"2017","journal-title":"N Engl J Med"},{"key":"R57-18-20200527","first-page":"CD012984","article-title":"Tocilizumab for thyroid eye disease","volume":"11","author":"Hamed Azzam","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"R58-18-20200527","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2174\/1871530318666180702150243","article-title":"Successful treatment for severe thyroid-associated ophthalmopathy with tocilizumab","volume":"18","author":"Canas","year":"2018","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"R61-18-20200527","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/cen.13970","article-title":"Early low-dose rituximab for active thyroid eye disease: an effective and well tolerated treatment","volume":"91","author":"Insull","year":"2019","journal-title":"Clin Endocrinol (Oxf"},{"key":"R64-18-20200527","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/phar.2111","article-title":"Efficacy and safety of rituximab for the treatment of Graves\u2019 orbitopathy: a meta-analysis of randomised controlled trials","volume":"38","author":"Shen","year":"2018","journal-title":"Pharmacotherapy"},{"key":"R65-18-20200527","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/IOP.0b013e3180500d57","article-title":"Rapamycin for treatment of refractory dysthyroid compressive optic neuropathy","volume":"23","author":"Chang","year":"2007","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"R66-18-20200527","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41433-019-0340-3","article-title":"Sirolimus (rapamycin) for the targeted treatment of the fibrotic sequelae of Graves\u2019 orbitopathy","volume":"33","author":"Roos","year":"2019","journal-title":"Eye (Lond"},{"key":"R67-18-20200527","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.gene.2018.11.097","article-title":"Novel role of SF1 in alleviating thyroid-associated ophthalmopathy through the AMPK\/mTOR signaling pathway","volume":"691","author":"Wang","year":"2019","journal-title":"Gene"},{"key":"R68-18-20200527","first-page":"185","article-title":"Antifibrotic effect of pirfenidone on orbital fibroblasts in patients with thyroid-associated ophthalmopathy and its mechanisms","volume":"58","author":"Li","year":"2019","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"R69-18-20200527","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.7150\/ijbs.24151","article-title":"Molecular alteration analysis of human gut microbial composition in Graves\u2019 disease patients","volume":"14","author":"Ishaq","year":"2018","journal-title":"Int J Biol Sci"},{"key":"R70-18-20200527","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s40168-018-0478-4","article-title":"Gut microbiota in experimental murine model of Graves\u2019 orbitopathy established in different environments may modulate clinical presentation of disease","volume":"6","author":"Masetti","year":"2018","journal-title":"Microbiome"},{"key":"R71-18-20200527","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41433-018-0303-0","article-title":"Comment on: A British Ophthalmic Surveillance Unit (BOSU) study into dysthyroid optic neuropathy in the United Kingdom","volume":"33","author":"Roos","year":"2019","journal-title":"Eye (Lond"},{"key":"R72-18-20200527","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1001\/jamaophthalmol.2014.5103","article-title":"Risk factors for developing thyroid-associated ophthalmopathy among individuals with Graves disease","volume":"133","author":"Stein","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"R73-18-20200527","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1089\/thy.2017.0430","article-title":"High serum cholesterol is a novel risk factor for Graves\u2019 orbitopathy: results of a cross-sectional study","volume":"28","author":"Sabini","year":"2018","journal-title":"Thyroid"},{"key":"R74-18-20200527","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1007\/s40618-018-0915-z","article-title":"Relationship between serum cholesterol and Graves\u2019 orbitopathy (GO): a confirmatory study","volume":"41","author":"Lanzolla","year":"2018","journal-title":"J Endocrinol Invest"},{"key":"R75-18-20200527","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jaapos.2018.04.009","article-title":"The effect of oral statin therapy on strabismus in patients with thyroid eye disease","volume":"22","author":"Reynolds","year":"2018","journal-title":"J AAPOS"},{"key":"R76-18-20200527","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1089\/thy.2018.0349","article-title":"A new highly thyrotropin receptor-selective small-molecule antagonist with potential for the treatment of Graves\u2019 orbitopathy","volume":"29","author":"Marcinkowski","year":"2019","journal-title":"Thyroid"},{"key":"R77-18-20200527","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1080\/08820139.2017.1319382","article-title":"Role of different CD40 polymorphisms in Graves\u2019 disease and Hashimoto's thyroiditis","volume":"46","author":"Wang","year":"2017","journal-title":"Immunol Invest"},{"key":"R78-18-20200527","doi-asserted-by":"crossref","first-page":"5391","DOI":"10.1167\/iovs.18-25466","article-title":"CD40 enhances sphingolipids in orbital fibroblasts: potential role of sphingosine-1-phosphate in inflammatory T-cell migration in Graves\u2019 orbitopathy","volume":"59","author":"Pl\u00f6hn","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R79-18-20200527","doi-asserted-by":"crossref","first-page":"e14162","DOI":"10.1097\/MD.0000000000014162","article-title":"Effect of orbital decompression on dysthyroid optic neuropathy: a retrospective case series","volume":"98","author":"Liang","year":"2019","journal-title":"Medicine (Baltimore"},{"key":"R80-18-20200527","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41433-018-0259-0","article-title":"Evolution of thyroid eye disease decompression-dysthyroid optic neuropathy","volume":"33","author":"Tooley","year":"2019","journal-title":"Eye (Lond"},{"key":"R81-18-20200527","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s40618-018-0847-7","article-title":"Rehabilitative orbital decompression for Graves\u2019 orbitopathy: results of a randomized clinical trial","volume":"41","author":"Sellari-Franceschini","year":"2018","journal-title":"J Endocrinol Invest"},{"key":"R82-18-20200527","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0161-6420(86)33712-6","article-title":"The four stages of surgical rehabilitation of the patient with dysthyroid ophthalmopathy","volume":"93","author":"Shorr","year":"1986","journal-title":"Ophthalmology"},{"key":"R83-18-20200527","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1093\/asj\/sjy014","article-title":"Simultaneous aesthetic eyelid surgery and orbital decompression for rehabilitation of thyroid eye disease: the one-stage approach","volume":"38","author":"Bernardini","year":"2018","journal-title":"Aesthet Surg J"},{"key":"R84-18-20200527","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1093\/asj\/sjy085","article-title":"Commentary on: simultaneous aesthetic eyelid surgery and orbital decompression for rehabilitation of thyroid eye disease: the one-stage approach","volume":"38","author":"Douglas","year":"2018","journal-title":"Aesthet Surg J"},{"key":"R86-18-20200527","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.ophtha.2006.10.036","article-title":"Reactivation of Graves\u2019 orbitopathy after rehabilitative orbital decompression","volume":"114","author":"Baldeschi","year":"2007","journal-title":"Ophthalmology"},{"key":"R87-18-20200527","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41433-018-0242-9","article-title":"Serial TSH-receptor antibody levels to guide the management of thyroid eye disease: the impact of smoking, immunosuppression, radio-iodine, and thyroidectomy","volume":"33","author":"Roos","year":"2019","journal-title":"Eye (Lond"},{"key":"R88-18-20200527","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000444796","article-title":"Comparison of early total thyroidectomy with antithyroid treatment in patients with moderate-severe Graves\u2019 orbitopathy: a randomized prospective trial","volume":"5","author":"Erdo\u011fan","year":"2016","journal-title":"Eur Thyroid J"},{"key":"R89-18-20200527","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s12262-016-1516-8","article-title":"Regression of ophthalmopathic exophthalmos in Graves\u2019 disease after total thyroidectomy: a prospective study of a surgical series","volume":"79","author":"Bhargav","year":"2017","journal-title":"Indian J Surg"},{"key":"R90-18-20200527","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1186\/s13063-018-2876-0","article-title":"Total thyroidectomy (Tx) versus thionamides (antithyroid drugs) in patients with moderate-to-severe Graves\u2019 ophthalmopathy - a 1-year follow-up: study protocol for a randomized controlled trial","volume":"19","author":"Brammen","year":"2018","journal-title":"Trials"}],"container-title":["Current Opinion in Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ICU.0000000000000596","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T09:20:48Z","timestamp":1695028848000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/ICU.0000000000000596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":78,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/icu.0000000000000596","relation":{},"ISSN":["1040-8738"],"issn-type":[{"value":"1040-8738","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]}}}